• Feature ArticlesFeature Articles

    Visualizing Data

    • 12 December 2018
    This article discusses the history of making data visual and suggest ways to keep viewers of visual data engaged. 
  • Regulatory NewsRegulatory News

    Data Integrity Q&A: FDA Finalizes Guidance

    • 12 December 2018
    The US Food and Drug Administration (FDA) on Wednesday finalized its questions and answers guidance on complying with data integrity requirements under current good manufacturing practice (CGMP) for drugs and biologics.
  • Regulatory NewsRegulatory News

    FDA Tweaks Final Guidance for PMAs and Device BLAs

    • 12 December 2018
    The US Food and Drug Administration (FDA) made minor revisions to a 2017 final guidance on Wednesday on user fees and refunds for premarket approval applications and device biologics license applications.
     
  • Regulatory NewsRegulatory News

    CBO Offers Positive Score for Senate Bill to Reform OTC Drug Regulations

    • 12 December 2018
    The Congressional Budget Office (CBO) this week said that a Senate bill that would create a new user fee program for over-the-counter (OTC) drugs would not increase the budget deficit.
     
  • Regulatory NewsRegulatory News

    FDA Warns China’s Zhejiang Huahai Over Failures to Detect Impurities in Valsartan API Batches

    • 11 December 2018
    China-based Zhejiang Huahai Pharmaceuticals drew a US Food and Drug Administration (FDA) warning letter over failures to conduct investigations into impurities classified as probable human carcinogens.
     
  • Regulatory NewsRegulatory News

    House Floats Five Year Extension of Medical Device Tax

    • 11 December 2018
    The widely unpopular medical device excise tax would be delayed for another five years under a tax relief package introduced by the US House Ways and Means Committee on Monday.
     
  • Feature ArticlesFeature Articles

    Safety First

    • 11 December 2018
    This article reviews the development of global Good Distribution Practices (GDPs) against the background of an increasingly complex pharmaceutical supply chain, five years after the initial implementation of the extended EU GDP Guideline.
  • Regulatory NewsRegulatory News

    FDA Rolls Out Expectations for Biosimilars, Soon-to-Be Biologics

    • 11 December 2018
    The US Food and Drug Administration (FDA) on Tuesday released two new draft Q&A guidance documents on biosimilar development and the deemed to be a license provision of the Biologics Price Competition and Innovation Act of 2009 (BPCIA), as well as two final guidance documents on the same topics and one proposed rule amending the definition of a biological product.
     

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Most Viewed Articles

Regulatory Focus ArticlesRSS 2.0